The European Society of Cardiology working group on heart failure: Heart Failure Update 2003.
D002227:Carbazoles / Q000627:therapeutic use*; D002304:Cardiac Pacing, Artificial; D000077261:Carvedilol; D000077545:Eplerenone; D005060:Europe; D006333:Heart Failure / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D006801:Humans; D008790:Metoprolol / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000150:complications; D011379:Prognosis; D011412:Propanolamines / Q000627:therapeutic use*; D013148:Spironolactone / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis; D014527:Uric Acid / Q000032:analysis
D002227:Carbazoles; D011412:Propanolamines; D014409:Tumor Necrosis Factor-alpha; D000077261:Carvedilol; D014527:Uric Acid; D013148:Spironolactone; D000077545:Eplerenone; D008790:Metoprolol